- Recommendation ID
- IPG755/1
- Question
Evidence on the safety and efficacy of percutaneous thoracic duct embolisation for persistent chyle leak is limited in quantity and quality. Therefore, this procedure should only be used with special arrangements for clinical governance, consent, and audit or research. Find out what special arrangements mean on the NICE interventional procedures guidance page.
- Any explanatory notes
(if applicable) NICE encourages further research into percutaneous thoracic duct embolisation for persistent chyle leak. Research should include details of patient selection, size and position of the leak, approaches used, and short- and long-term efficacy and safety outcomes.
Source guidance details
- Comes from guidance
- Percutaneous thoracic duct embolisation for persistent chyle leak
- Number
- IPG755
- Date issued
- April 2023
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 05/05/2023 |